Brigola, Sestan Khart Q.

HRN: 23-00-79  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/19/2023
AMPICILLIN 500MG (VIAL)
05/19/2023
05/25/2023
IVT
160mg
Q12
Potentially Septic Newborn
Waiting Final Action 
05/19/2023
GENTAMICIN 40MG/ML, 2ML (AMP)
05/19/2023
05/25/2023
IVTT
16mg
Q24h
Potentially Septic Newborn
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: